Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 155
- −21 vs. Q4 2025
- Portfolio value
- $4.20B
- −$1.07B (−20.4%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GKOSGLAUKOS Corp | COM | 145,703 | $15.7M | 0.4% | −116,232−44.4% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 37,765 | $17.9M | 0.4% | −6,141−14.0% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 121,887 | $19.2M | 0.5% | −143,775−54.1% | Reduced | History |
| MCKMcKesson Corp | Stock | 22,352 | $19.3M | 0.5% | −2,746−10.9% | Reduced | History |
| COOCooper Companies, Inc. | COM | 272,184 | $19.5M | 0.5% | −19,775−6.8% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 93,567 | $20.3M | 0.5% | −41,292−30.6% | Reduced | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 1,250,000 | $20.6M | 0.5% | +1,250,000 | New | History |
| GMEDGlobus Medical Inc | Stock | 247,261 | $21.3M | 0.5% | −15,422−5.9% | Reduced | History |
| STESTERIS plc | SHS USD | 99,878 | $22.1M | 0.5% | −1,827−1.8% | Reduced | History |
| ALGNAlign Technology Inc | COM | 139,680 | $23.9M | 0.6% | −1,794−1.3% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 206,591 | $24.9M | 0.6% | +114,474+124.3% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 507,008 | $24.9M | 0.6% | +507,008 | New | History |
| CICigna Group | Stock | 98,263 | $26.2M | 0.6% | −11,750−10.7% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $28.6M | 0.7% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 119,102 | $29.1M | 0.7% | −7,698−6.1% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 459,314 | $29.4M | 0.7% | +459,314 | New | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 416,887 | $29.7M | 0.7% | −7,627−1.8% | Reduced | History |
| LLYEli Lilly & Co | Stock | 33,932 | $31.2M | 0.7% | −71−0.2% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 64,412 | $31.7M | 0.8% | −665−1.0% | Reduced | History |
| PODDInsulet Corp | Stock | 163,656 | $34.3M | 0.8% | −23,043−12.3% | Reduced | History |
| RMDResmed Inc | COM | 159,346 | $35.8M | 0.9% | −1,868−1.2% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,200,000 | $38.1M | 0.9% | −2,417,669−66.8% | Reduced | History |
| DHRDanaher Corp | Stock | 202,164 | $38.3M | 0.9% | +7,531+3.9% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 148,203 | $40.1M | 1.0% | −26,966−15.4% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,528,518 | $48.1M | 1.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,501,502 | $49.2M | 1.2% | +160,399+4.8% | Added | History |
| DXCMDexcom Inc | COM | 788,766 | $49.5M | 1.2% | −58,639−6.9% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 2,380,000 | $49.9M | 1.2% | +2,377,420+92,148.1% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 89,131 | $50.1M | 1.2% | −5,408−5.7% | Reduced | History |
| TNGXTango Therapeutics, Inc. | COM | 2,400,000 | $50.2M | 1.2% | −1,527,670−38.9% | Reduced | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 2,298,000 | $59.5M | 1.4% | +2,298,000 | New | History |
| EWEdwards Lifesciences Corp | Stock | 839,451 | $67.2M | 1.6% | −203,645−19.5% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 1,710,771 | $68.8M | 1.6% | +12,619+0.7% | Added | History |
| PCVXVaxcyte, Inc. | COM | 1,190,697 | $69.2M | 1.6% | +1,190,697 | New | History |
| SYKStryker Corp | Stock | 217,237 | $71.4M | 1.7% | −143,340−39.8% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 7,795,242 | $77.6M | 1.8% | −550,122−6.6% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 234,543 | $77.6M | 1.8% | −211,360−47.4% | Reduced | History |
| MDTMedtronic plc | Stock | 957,329 | $83.0M | 2.0% | +190,737+24.9% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 2,796,803 | $84.3M | 2.0% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 2,320,867 | $91.0M | 2.2% | +2,320,867 | New | History |
| BSXBoston Scientific Corp | Stock | 1,466,894 | $92.0M | 2.2% | −92,712−5.9% | Reduced | History |
| AMGNAmgen Inc | Stock | 295,358 | $103.9M | 2.5% | +276,869+1,497.5% | Added | History |
| NUVLNuvalent, Inc. | COM | 1,053,268 | $107.9M | 2.6% | +15,800+1.5% | Added | History |
| ABTAbbott Laboratories | Stock | 1,151,635 | $118.2M | 2.8% | −165,280−12.6% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,280,000 | $119.1M | 2.8% | +3,275,960+81,088.1% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 481,785 | $124.5M | 3.0% | +71,462+17.4% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 6,726,144 | $131.6M | 3.1% | +2,367,617+54.3% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 286,654 | $132.1M | 3.1% | −35,374−11.0% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 1,818,665 | $136.6M | 3.2% | −2,983,534−62.1% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 1,544,456 | $150.2M | 3.6% | −3,461,263−69.1% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 1,169,879 | $163.0M | 3.9% | +1,117,127+2,117.7% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 3,584,573 | $176.2M | 4.2% | −472,019−11.6% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 278,674 | $215.3M | 5.1% | +264,746+1,900.8% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 313,000 | $228.6M | 5.4% | −148,854−32.2% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 681,908 | $304.5M | 7.2% | +788+0.1% | Added | History |
Sold out since Q4 2025 (40)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc.05370A108 | COM | 2,630,969 | $189.8M | 3.6% | – |
| FOLDAmicus Therapeutics, Inc. | COM | 10,735,195 | $152.9M | 2.9% | History |
| MAZEMaze Therapeutics, Inc. | COM | 887,708 | $36.8M | 0.7% | History |
| CDNACareDx, Inc. | COM | 431,070 | $8.12M | 0.2% | History |
| MOHMolina Healthcare, Inc. | COM | 46,626 | $8.09M | 0.2% | History |
| ICLRIcon PLC | COM | 24,560 | $4.48M | 0.1% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 65,008 | $3.86M | 0.1% | History |
| BTSGBrightSpring Health Services, Inc. | COM | 92,095 | $3.45M | 0.1% | History |
| NEONeogenomics Inc | COM NEW | 278,286 | $3.27M | 0.1% | History |
| AVTRAvantor, Inc. | COM | 276,266 | $3.17M | 0.1% | History |
| BEAMBeam Therapeutics Inc. | COM | 111,510 | $3.09M | 0.1% | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 30,431 | $2.80M | 0.1% | History |
| VKTXViking Therapeutics, Inc. | COM | 68,665 | $2.42M | <0.1% | History |
| ROIVRoivant Sciences Ltd. | SHS | 108,039 | $2.34M | <0.1% | History |
| BKDBrookdale Senior Living Inc. | COM | 167,444 | $1.81M | <0.1% | History |
| SIBNSI-BONE, Inc. | COM | 90,331 | $1.78M | <0.1% | History |
| EXASExact Sciences Corp | COM | 16,062 | $1.63M | <0.1% | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 142,243 | $981.5K | <0.1% | History |
| ANETArista Networks, Inc. | Stock | 4,800 | $628.9K | <0.1% | History |
| iShares Russell 2000 ETF464287655 | ETF | 2,300 | $566.2K | <0.1% | – |
| METAMeta Platforms, Inc. | Stock | 800 | $528.1K | <0.1% | History |
| DOCSDoximity, Inc. | CL A | 11,817 | $523.3K | <0.1% | History |
| LULUlululemon athletica inc. | Stock | 2,240 | $465.5K | <0.1% | History |
| PLTRPalantir Technologies Inc. | Stock | 2,500 | $444.4K | <0.1% | History |
| CORTCorcept Therapeutics Inc | COM | 10,495 | $365.2K | <0.1% | History |
| PLNTPlanet Fitness, Inc. | CL A | 3,173 | $344.2K | <0.1% | History |
| EXELExelixis, Inc. | COM | 7,361 | $322.6K | <0.1% | History |
| GHGuardant Health, Inc. | COM | 3,004 | $306.8K | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 5,851 | $283.5K | <0.1% | History |
| MRNAModerna, Inc. | Stock | 7,711 | $227.4K | <0.1% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 4,942 | $170.8K | <0.1% | History |
| CGONCG Oncology, Inc. | COM | 3,095 | $128.5K | <0.1% | History |
| QUREuniQure N.V. | SHS | 4,763 | $114.0K | <0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,210 | $105.8K | <0.1% | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 7,913 | $99.7K | <0.1% | History |
| TRVITrevi Therapeutics, Inc. | COM | 7,603 | $95.2K | <0.1% | History |
| GMABGenmab A/S | SPONSORED ADS | 3,009 | $92.7K | <0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 3,143 | $82.6K | <0.1% | History |
| ORICOric Pharmaceuticals, Inc. | COM | 9,706 | $79.4K | <0.1% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 2,978 | $26.8K | <0.1% | History |